Results 31 to 40 of about 3,182,211 (266)

Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008-2019.

PLoS ONE, 2020
ObjectiveCurrent guidelines in British Columbia recommend prenatal screening for hepatitis C antibodies (anti-HCV) if risk factors are present. We aimed to estimate frequency of prenatal anti-HCV testing, new diagnoses, repeated and follow-up testing ...
Margo E Pearce, Amanda Yu, Maria Alvarez, Sofia R Bartlett, Mawuena Binka, Dahn Jeong, Emilia Clementi, Prince Adu, James Wilton, Eric M Yoshida, Neora Pick, Jane A Buxton, Jason Wong, Agatha Jassem, Mel Krajden, Naveed Z Janjua   +15 more
doaj   +1 more source

A study based on four immunoassays: Hepatitis C virus antibody against different antigens may have unequal contributions to detection

Virology Journal, 2021
Background All commercial Hepatitis C virus antibody (anti-HCV) assays use a combination of recombinant antigens to detect antibody response. Antibody responses to individual antigenic regions (core, NS3/4 and NS5) used in assays have not been ...
Xinyi Jiang, Le Chang, Ying Yan, Huimin Ji, Huizhen Sun, Fei Guo, Lunan Wang   +6 more
doaj   +1 more source

Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan

Scientific Reports, 2021
The spreading of viral hepatitis among injecting drug users (IDU) is an emerging public health concern. This study explored the prevalence and the risks of hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus (HDV) among IDU-dominant ...
Ming-Ying Lu, Chun-Ting Chen, Yu-Lueng Shih, Pei-Chien Tsai, Meng-Hsuan Hsieh, Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, Shu-Chi Wang, Yi-Shan Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Wen-Yu Chang   +26 more
doaj   +1 more source

A step-wise approach to a national hepatitis C screening strategy in Malaysia to meet the WHO 2030 targets: proposed strategy, coverage, and costs [PDF]

, 2019
In Malaysia, more than 330 000 individuals are estimated to be chronically infected with hepatitis C virus (HCV), but less than 2% have been treated to date.
Azzeri, Amirah, Dahlui, Maznah, Hecht, Robert, Hiebert, Lindsey, McDonald, Scott A, Mohamed, Rosmawati, Shabaruddin, Fatiha, Soe-Lin, Shan, Syed Mansor, Syed Mukhtar   +8 more
core   +1 more source

Evaluation of the automated fluorescent immunoassay system anti-hepatitis C virus assay for the detection of hepatitis C virus infection

Global Journal of Transfusion Medicine, 2019
Introduction: Hepatitis C has emerged as a fatal epidemic in the country in the past two decades. One of the major risk factors remains unsafe blood transfusions.
Usman Waheed, Min-woong Hwang, Noor e Saba, Sooncheol Hong, Muhammad Saeed, Akhlaaq Wazeer, Muhammad Arshad, Javaid Usman, Hasan Abbas Zaheer   +8 more
doaj   +1 more source

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents [PDF]

, 2014
Hepatitis C virus (HCV) is transmitted between hepatocytes via classical cell entry but also uses direct cell-cell transfer to infect neighboring hepatocytes.
A Owsianka, A Sigal, Aleem Siddiqui, Arvind H. Patel, AS Lok, AW Tarr, B Bartolini, B Sainz Jr, C Hezode, C Lee, C Nathan, C Sarrazin, CL Brimacombe, CM Lange, CT Jones, D Masson, D Trono, EJ Gane, Eric Soulier, F Kuonen, F Poordad, F Poordad, Fei Xiao, François Habersetzer, G Koutsoudakis, H Kwon, H Yan, H Zhu, Heidi Barth, I Fofana, I Fofana, I Fofana, IA Abela, IM Jacobson, Isabel Fofana, J Grove, J Lupberger, J Witteveldt, J Zhong, Jens Bukh, JG McHutchison, JM Gottwein, JM Gottwein, JM Pawlotsky, JM Pawlotsky, JM Pawlotsky, JM Timpe, L Rong, L Zona, Laura Heydmann, LW Meredith, MB Zeisel, MB Zeisel, Michel Doffoël, Mirjam B. Zeisel, MN Zahid, MS Sulkowski, MT Catanese, N Shi, O Lenz, P Zhong, PM Trembling, Q Sattentau, S Haid, T Pietschmann, T Pietschmann, T Wakita, Thomas F. Baumert, TJ Liang, TK Scheel, V Soriano, VD Cataldo, ZY Keck   +72 more
core   +7 more sources

Spatial mapping of hepatitis C prevalence in recent injecting drug users in contact with services. [PDF]

, 2011
In developed countries the majority of hepatitis C virus (HCV) infections occur in injecting drug users (IDUs) with prevalence in IDUs often high, but with wide geographical differences within countries.
A. MORONGIU, Bajekal, Brooks, D. DE ANGELIS, F. NCUBE, Ghangurde, Hope, Hope, Kelsall, M. HICKMAN, Martin, R. J. HARRIS, Spiegelhalter, V. D. HOPE   +13 more
core   +1 more source

Comparison of HCV core antigen and anti-HCV with HCV RNA results.

African Health Sciences, 2015
BACKGROUND The measurement of anti-HCV antibodies using immunological methods and the confirmation of viral nuclear acid based on molecular methods is important in diagnosis and follow-up of the HCV infection.
Cicioğlu Arıdoğan Buket, Aynali Ayşe, Kaya Selçuk, Önal Süleyman, Sesli Çetin Emel   +4 more
semanticscholar   +1 more source

Analysis of reactive HCV results detected by current blood screening strategy

Zhongguo shuxue zazhi, 2022
Objective To assess the status of HCV infection by analyzing the results of anti-HCV reactive blood samples detected by the current blood testing strategy, and discuss the viability of classified management of reactive blood donors.
ZhengMin LIU, Rui WANG, Jin GUO, Jing ZHANG, Yi ZHA, Hongwei GE, Ling LI   +6 more
doaj   +1 more source

The Usefulness of Anti-HCV Signal to Cut-off Ratio in Predicting Viremia in Anti-HCV in Patients With Hepatitis C Virus Infection

Jundishapur Journal of Microbiology, 2015
Background: Hepatitis C Virus (HCV) infection is diagnosed by antibody and RNA based methods. Patients with anti-HCV sample rate/cutoff rate (S/CO) ratios > 1 are reported as anti-HCV positive.
Fahimeh Ranjbar Kermani, Z. Sharifi, Fereshteh Ferdowsian, Zahrah Paz, Farzaneh Tavassoli   +4 more
semanticscholar   +1 more source